PL376918A1 - Prolek celekoksybu - Google Patents

Prolek celekoksybu

Info

Publication number
PL376918A1
PL376918A1 PL376918A PL37691803A PL376918A1 PL 376918 A1 PL376918 A1 PL 376918A1 PL 376918 A PL376918 A PL 376918A PL 37691803 A PL37691803 A PL 37691803A PL 376918 A1 PL376918 A1 PL 376918A1
Authority
PL
Poland
Prior art keywords
celecoxib
prodrug
celecoxib prodrug
Prior art date
Application number
PL376918A
Other languages
English (en)
Inventor
Matthew J. Graneto
Gary D. Ewing
Original Assignee
Pharmacia Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corporation filed Critical Pharmacia Corporation
Publication of PL376918A1 publication Critical patent/PL376918A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL376918A 2002-11-12 2003-11-03 Prolek celekoksybu PL376918A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42570302P 2002-11-12 2002-11-12

Publications (1)

Publication Number Publication Date
PL376918A1 true PL376918A1 (pl) 2006-01-09

Family

ID=32313040

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376918A PL376918A1 (pl) 2002-11-12 2003-11-03 Prolek celekoksybu

Country Status (17)

Country Link
US (1) US20040092566A1 (pl)
EP (1) EP1562910A1 (pl)
JP (1) JP2006508123A (pl)
KR (1) KR20050072823A (pl)
CN (1) CN1711247A (pl)
AR (1) AR042037A1 (pl)
AU (1) AU2003291278A1 (pl)
BR (1) BR0316155A (pl)
CA (1) CA2505635A1 (pl)
CO (1) CO5700738A2 (pl)
MX (1) MXPA05004991A (pl)
NO (1) NO20052813L (pl)
PL (1) PL376918A1 (pl)
RU (1) RU2005114398A (pl)
TW (1) TW200424179A (pl)
WO (1) WO2004043934A1 (pl)
ZA (1) ZA200503188B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1579198A1 (en) * 2002-12-30 2005-09-28 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
JP2008520569A (ja) * 2004-11-16 2008-06-19 メルク エンド カムパニー インコーポレーテッド 卒中を治療するための（２ｒ）−２−プロピルオクタン酸のプロドラッグ
CN101805290A (zh) * 2010-04-01 2010-08-18 中国人民解放军第四军医大学 氨基磺酰吡唑类化合物及其用途
BRPI1003050B1 (pt) * 2010-08-04 2021-05-25 Universidade Federal De Minas Gerais Compostos derivados do ácido araquidônico substituídos com análogos de coxibes para tratamento de dor
KR101245078B1 (ko) * 2010-11-11 2013-03-18 부산대학교 산학협력단 대장 선택성 셀레콕시브 전구체 화합물 및 이를 유효성분으로 함유하는 대장성 질환 치료 또는 예방용 약학조성물
JP2015501802A (ja) * 2011-11-17 2015-01-19 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ 眼への薬物送達を向上させるための方法および組成物、ならびに徐放性送達製剤
CN104892514A (zh) * 2015-05-19 2015-09-09 广州诺威生物技术有限公司 一种咪唑类新化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0892791B1 (en) * 1996-04-12 2003-03-05 G.D. Searle & Co. N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS

Also Published As

Publication number Publication date
JP2006508123A (ja) 2006-03-09
RU2005114398A (ru) 2006-01-20
KR20050072823A (ko) 2005-07-12
NO20052813D0 (no) 2005-06-10
WO2004043934A1 (en) 2004-05-27
ZA200503188B (en) 2006-11-29
AR042037A1 (es) 2005-06-08
AU2003291278A1 (en) 2004-06-03
CA2505635A1 (en) 2004-05-27
BR0316155A (pt) 2005-09-27
CN1711247A (zh) 2005-12-21
US20040092566A1 (en) 2004-05-13
EP1562910A1 (en) 2005-08-17
CO5700738A2 (es) 2006-11-30
NO20052813L (no) 2005-08-02
TW200424179A (en) 2004-11-16
MXPA05004991A (es) 2005-08-02

Similar Documents

Publication Publication Date Title
GB0229618D0 (en) Pyrazole compounds
EP1558585A4 (en) NEUROLOGICALLY ACTIVE COMPOUNDS
GB0209022D0 (en) Compounds
HK1145463A1 (en) Remedy
GB0200283D0 (en) Compounds
HRP20050162A2 (en) ?-lactamase inhibitor prodrug
AU2003216859A8 (en) Amidoacetonitrile compounds
PL376918A1 (pl) Prolek celekoksybu
EP1491205A4 (en) MEANS FOR THE TREATMENT OF HYPERMYOTONIA
GB0210762D0 (en) Compounds
GB0225750D0 (en) Wiffs away
GB0211418D0 (en) Compounds
GB0207323D0 (en) Compounds
GB0212399D0 (en) Compounds
GB0203778D0 (en) Compounds
GB0209244D0 (en) Compounds
AU2003275480A8 (en) Compounds
GB0203811D0 (en) Compounds
GB0206981D0 (en) Compounds
GB0208087D0 (en) Biocides
AU2002251330A1 (en) Celecoxib forms
GB0204065D0 (en) Compounds
GB0209320D0 (en) Compounds
GB0204721D0 (en) Compounds
GB0204784D0 (en) Compounds

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)